Connect with us

Saskatchewan Roughriders

CFL suspends Bruce Campbell for two games following positive test for banned substance

The CFL suspended offensive lineman Bruce Campbell of the Saskatchewan Roughriders for two games after testing positive for a banned substance.

Campbell, an American, tested positive for Ibutamoren, which has anabolic benefits that promote an increase in lean body mass.

It’s Campbell’s first violation of the league’s drug policy, thus resulting in the two-game suspension.

↑ what lands at 3 p.m. daily
3DownNation Daily

Get game analysis, stats, and more daily at 3pm

Here’s exactly what you’ll get.

One email. Every weekday at 3 p.m. Your daily CFL briefing.
  • Canadian football's biggest stories
  • Smart game analysis
  • Every CFL transaction covered with exclusive insight

The six-foot-seven, 317-pound Campbell won’t be able to play for two games this upcoming season but it will be up to the Riders to decide if he’ll be able to participate in other team activities such as practices and meetings.

In a statement, Campbell said he won’t appeal the league’s ruling.

“First, I would like to apologize to the Saskatchewan Roughriders organization and my teammates for putting them in this position,” he said. “I’d also like to apologize to Rider fans and fans across the league.

“I take full responsibility for my actions and ensure you it will not happen again. I accept the Canadian Football League decision and will not be appealing the two-game suspension.”

Added Chris Jones, the Riders head coach/GM: “As an organization, we fully support the CFL and CFLPA policy to prevent the use of performance-enhancing drugs. We are disappointed to learn that a member of our team has committed a violation. We have spoken with Bruce and he has taken ownership of his decision and realizes the impact of this violation.”

-CP

Sign up for the 3DownNation daily newsletter

Sign up to be updated with all the latest news, offers, and special announcements.

3DownNation Podcast


From 3DownNation Reporters

 


Our Top Stories